To include your compound in the COVID-19 Resource Center, submit it here.

Incyte, AZ to start Phase III trial for NSCLC

Incyte Corp. (NASDAQ:INCY) and AstraZeneca plc (LSE:AZN; NYSE:AZN) will begin a Phase

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE